MBCP Safety and Performance in the Osteonecrosis of Femur Head

NCT ID: NCT00289575

Last Updated: 2007-03-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-02-28

Study Completion Date

2008-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this pilot study is to evaluate MBCP performance in bone regeneration after osteonecrosis biopsy of the femur head. This technic may prevent the neck of the femur bone weakness following the healthy area drilling, thanks to a bone reconstruction at the expense of the biomaterial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Twelve patients will be enrolled in this study and evaluation of infection and inflammation of the drilled area, pain and hip function will be assessed during a one year follow up. Bone reconstruction will be evaluated with scanner and radiography.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteonecrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MBCP

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* femur head osteonecrosis (1 to 2 level in ARCO scale)
* signed informed consent

Exclusion Criteria

* primary bone infection
* femur head sphericity loss
* cancer, diabetes, tuberculosis previous history
* HIV, Hepatitis B, Hepatitis C infection
* drepanocytosis
* current corticotherapy
* current immunosuppressive therapy
* innate or acquired immune deficience
* pregnancy or lack of efficient contraception
* current participation in an other study
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CIC Bordeaux

UNKNOWN

Sponsor Role collaborator

Biomatlante

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thierry FABRE, Pr

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Bordeaux

Jacques DEMOTES-MAINARD, Pr

Role: STUDY_CHAIR

Clinical Research Center INSERM/Bordeaux University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de chirurgie orthopédique et traumatologique- Hôpital Pellegrin

Bordeaux, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Thierry FABRE, Pr

Role: CONTACT

+33556795544

Dominique CHAUVEAUX, Pr

Role: CONTACT

+33556795679

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Thierry FABRE, ¨Pr

Role: primary

+33556795544

Dominique CHAUVEAUX, pr

Role: backup

+33556795679

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

63

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effectiveness of 3D Bone Matrix in Cranioplasty
NCT06792864 ENROLLING_BY_INVITATION PHASE3